Belimumab with rituximab for treating systemic lupus erythematosus [ID3967]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Obinutuzumab for treating lupus nephritis TID6420Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC